MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David Dardashti's Ibogaine has been leading ...
A groundbreaking collaboration provides useful advice on a clinically challenging problem. Depression is common in women during the childbearing years, and psychiatrists and obstetricians alike can ...
Treatment-Resistant Depression companies working in the market are Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, Beckley Psytech, COMPASS Pathways, Axsome Therapeutics ...
"Treatment-Resistant Depression Treatment Market"Treatment-Resistant Depression companies working in the market are Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results